What's New
Front Page
Emma Heming Willis Shares Insights from Her Family’s FTD Journey in Essay
In an essay published in Maria Shriver’s Sunday Paper, Emma Heming Willis shared some insights she has…
Dear HelpLine – Support for Veterans
Dear HelpLine, My loved one is a veteran. Do we qualify for any support? Navigating the Department…
Provide Help and Bring Hope with a Year-End Gift
AFTD was founded more than 20 years ago with a single donation. Since then, the dedication and…
AFTD Ambassador Shares Challenges of Being a Long-Distance Care Partner in Interview
AFTD Ambassador Melissa Fisher shared the realities of being a long-distance care partner in an interview published…
FDA Clears Way for Clinical Trial for AviadoBio Therapy That Could Halt FTD Progression
AviadoBio will soon open U.S. clinical trial sites for an experimental gene therapy that could halt the…
AFTD Update: Updated Digital Resources for FTD & Genetics
The FTD & Genetics section of AFTD’s website has been newly updated to help families better understand…
Landmark Trial Evaluating Potential FTD-GRN Therapeutic Completes Enrollment
Biotechnology company Alector Therapeutics announced on October 27 that it has completed enrollment for INFRONT-3, a Phase…
The Lived Experience of FTD: Anosognosia
The following article was written by Kevin Rhodes, a member of AFTD’s Persons with FTD Advisory Council….
AFTD Webinar: Grief, Loss, and Hope — Helping Families Living with FTD
FTD is the most common dementia for people under 60, and often occurs when there are teens…
Doctor Living with FTD Discusses Life Post-Diagnosis in Interview
In an interview recently broadcast by Atlanta News First, former gynecologist Dr. Seth Stern discussed his work…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)